1. Network Pharmacology Study on the Pharmacological Mechanism of Cinobufotalin Injection against Lung Cancer
   Yun Mao et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
2. Antiangiogenic Properties of Axitinib versus Sorafenib Following Sunitinib Resistance in Human Endothelial Cells—A View towards Second Line Renal Cell Carcinoma Treatment
   Eva Juengel et al, 2021, Biomedicines CrossRef
3. The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
   Han-yu Jiang et al, 2022, OTT CrossRef
4. The Integrated Study on the Chemical Profiling to Explore the Constituents and Mechanism of Traditional Chinese Medicine Preparation Huatuo Jiuxin Pills Based on UPLC-Q-TOF/MSE and Network Pharmacology
   Yulong Zhu et al, 2022, Front. Mol. Biosci. CrossRef
5. Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology
   Jianbo Zhou et al, 2022, Front. Pharmacol. CrossRef
6. Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma
   Lai Wei et al, 2022, Chin Med CrossRef
7. ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
   Laura Soumoy et al, 2024, Cancer Cell Int CrossRef
8. Multi-b-value DWI to evaluate the synergistic antiproliferation and anti-heterogeneity effects of bufalin plus sorafenib in an orthotopic HCC model
   Ran Guo et al, 2024, Eur Radiol Exp CrossRef
9. Influence of Different Ratios of DSPE-PEG2k on Ester Prodrug Self-Assembly Nanoparticles for Cell Migration and Proliferation Suppression
   Huiyun Zhang et al, 2024, IJN CrossRef
10. Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System
    Haiqing Wang et al, 2024, IJN CrossRef
11. Combinational Antitumor Strategies Based on the Active Ingredients of Toad Skin and Toad Venom
    Huan Tian et al, 2024, DDDT CrossRef